In a previous article about Econ Healthcare, I wrote about how I wasn’t interested to invest in the company for various reasons. Today, I add another key reason to that list and question their management’s investment decisions.

On January 9, it was reported that Econ Healthcare spent S$4 million buying shares of a Hong Kong listed firm Crosstec. The reason provided was that [they] “observed that ‘shares are on a rising trend’“, and that “the company is of the view that the potential gain on investment on quoted security will improve the yield of idle cash and therefore the return of the company’s shareholders”.

So, it was reported that Econ Healthcare had bought the shares at 29.26 cents and 40.04 cents (SGD). The next trading day , 𝗖𝗿𝗼𝘀𝘀𝘁𝗲𝗰 𝘀𝗵𝗮𝗿𝗲 𝗽𝗿𝗶𝗰𝗲 𝗽𝗹𝘂𝗻𝗴𝗲𝗱 𝟴𝟯% to close at 0.38 HKD (6.6 cents SGD).

When we zoom further out on the charts, we can see that the so-called uptrend only started in November.